tokens: A number of other trade names of subcutaneous immunoglobulin have since been approved , although some small-scale studies have indicated that a particular cohort of patients with Common variable immunodeficiency ( CVID ) may suffer intolerable side effects with subcutaneous immunoglobulin ( SCIg ) that they do not with intravenous immunoglobulin ( IVIg ) .